SINGAPORE (June 27): QT Vascular’s Chocolate XD propercutaneous transluminal coronary angioplasty (PTCA) balloon has received approvals from the US Food and Drug Administration for use in coronary interventions.

The Chocolate series of balloons uses a nitinol constraining structure that is designed to reduce vessel trauma by producing a balloon inflation that is predictable, controlled and uniform. The Chocolate XD in particular also has improved trackability and deliverability.

QT Vascular also added that a drug coated version of the Chocolate PTCA is currently in development, and plans to focus on the coronary market.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook